CytomX Therapeutics, Inc. (CTMX) — Analyst estimates
Consensus analyst estimates for CytomX Therapeutics, Inc. — earnings, revenue, and price targets.
| Fiscal Year | Revenue Forecast | EPS Forecast | analysts |
|---|---|---|---|
| 2026 | 7.11M | -0.11 | 2 |
| 2027 | 3.44M | -0.16 | 2 |
| 2028 | 35.68M | -0.52 | 4 |
| 2029 | 56.13M | -0.59 | 2 |
| 2030 | 204.16M | -0.11 | 2 |
Consensus analyst estimates by fiscal year.